ID: MRFR/HC/5993-HCR | 85 Pages | Author: Kinjoll Dey | March 2024
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Hyperpigmentation Disorders Treatment Market, by Treatment Type
6.1 Introduction
6.2 Topical Drugs
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
6.3 Chemical Peels
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
6.4 Microdermabrasion
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
6.5 Laser Therapy
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
6.6 Phototherapy
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
6.7 Others
Chapter 7. Global Hyperpigmentation Disorders Treatment Market, by Disease Indication
7.1 Introduction
7.2 Melasma
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
7.3 Solar Lentigines
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
7.3 Post-inflammatory Hyperpigmentation
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
7.3 Others
Chapter 8. Global Hyperpigmentation Disorders Treatment Market, by End-User
8.1 Introduction
8.2 Hospitals
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
8.3 Aesthetic Clinics & Dermatology Centers
Market Estimates & Forecast, by Region, 2023β2030
Market Estimates & Forecast, by Country, 2023β2030
8.4 Others
Chapter 9. Global Hyperpigmentation Disorders Treatment Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 12. Company Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Key Development & Strategies
Chapter 13. Company Profiles
13.1 Allergan, Inc.
13.1.1 Company Overview
13.1.2 Product Overview
13.1.3 Financials Overview
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Bayer AG
13.2.1 Company Overview
13.2.2 Product Overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 EpiPharm AG
13.3.1 Company Overview
13.3.2 Product Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 Episciences, Inc.
13.4.1 Company Overview
13.4.2 Technologys/Business Segment Overview
13.4.3 Financial Overview
13.4.4 Key Development
13.4.5 SWOT Analysis
13.5 Galderma laboratories (Nestle Skin Health S.A)
13.5.1 Company Overview
13.5.2 Product Overview
13.5.3 Financial overview
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.6 Obagi Cosmeceuticals LLC
13.6.1 Company Overview
13.6.2 Product Overview
13.6.3 Financial Overview
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.7 Pierre Fabre
13.7.1 Overview
13.7.2 Product Overview
13.7.3 Financial Overview
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 RXi Pharmaceuticals Corporation
13.8.1 Overview
13.8.2 Product/ Technology Overview
13.8.3 Financials
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.9 SkinCeuticals International
13.9.1 Overview
13.9.2 Product Overview
13.9.3 Financials
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.10 Vivier Pharma
13.10.1 Overview
13.10.2 Product Overview
13.10.3 Financials
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.11 Others
Chapter 14. MRFR Conclusion
14.1 Key Findings
14.1.1 From CEOβs Viewpoint
14.1.2 Unmet Needs of the Market
14.2 Key Companies to Watch
14.3 Predictions for the Hyperpigmentation Disorders Treatment Industry
Chapter 15. Appendix
LIST OF TABLES
Table 1 Global Hyperpigmentation Disorders Treatment Market Synopsis, 2023β2030
Table 2 Global Hyperpigmentation Disorders Treatment Market Estimates and Forecast, 2023β2030 (USD Million)
Table 3 Global Hyperpigmentation Disorders Treatment Market, by Region, 2023β2030 (USD Million)
Table 4 Global Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 5 Global Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 6 Global Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 7 North America: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 8 North America: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 9 North America: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 10 US: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 11 US: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 12 US: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 13 Canada: Hyperpigmentation Disorders Treatment Market,by Treatment Type, 2023β2030 (USD Million)
Table 14 Canada: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 15 Canada: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 16 South America: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 17 South America: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 18 South America: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 19 Europe: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 20 Europe: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 21 Europe: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 22 Western Europe: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 23 Western Europe: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 24 Western Europe: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 25 Eastern Europe: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 26 Eastern Europe: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 27 Eastern Europe: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 28 Asia-Pacific: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 29 Asia-Pacific: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 30 Asia-Pacific: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
Table 31 Middle East & Africa: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023β2030 (USD Million)
Table 32 Middle East & Africa: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023β2030 (USD Million)
Table 33 Middle East & Africa: Hyperpigmentation Disorders Treatment Market, by End-User, 2023β2030 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Hyperpigmentation Disorders Treatment Market
Figure 3 Segmentation Market Dynamics for Global Hyperpigmentation Disorders Treatment Market
Figure 4 Global Hyperpigmentation Disorders Treatment Market Share, by Treatment Type, 2023
Figure 5 Global Hyperpigmentation Disorders Treatment Market Share, by Disease Indication, 2023
Figure 6 Global Hyperpigmentation Disorders Treatment Market Share, by End-User, 2023
Figure 7 Global Hyperpigmentation Disorders Treatment Market Share, by Region, 2023
Figure 8 North America: Hyperpigmentation Disorders Treatment Market Share, by Country, 2023
Figure 9 Europe: Hyperpigmentation Disorders Treatment Market Share, by Country, 2023
Figure 10 Asia-Pacific: Hyperpigmentation Disorders Treatment Market Share, by Country, 2023
Figure 11 Middle East & Africa: Hyperpigmentation Disorders Treatment Market Share, by Region, 2023
Figure 12 Global Hyperpigmentation Disorders Treatment Market: Company Share Analysis, 2023 (%)
Figure 13 Allergan, Inc.: Key Financials
Figure 14 Allergan, Inc.: Segmental Revenue
Figure 15 Allergan, Inc.: Geographical Revenue
Figure 16 Bayer AG: Key Financials
Figure 17 Bayer AG: Segmental Revenue
Figure 18 Bayer AG: Geographical Revenue
Figure 19 EpiPharm AG: Key Financials
Figure 20 EpiPharm AG: Segmental Revenue
Figure 21 EpiPharm AG: Geographical Revenue
Figure 22 Episciences, Inc.: Key Financials
Figure 23 Episciences, Inc.: Segmental Revenue
Figure 24 Episciences, Inc.: Geographical Revenue
Figure 25 Galderma laboratories (Nestle Skin Health S.A): Key Financials
Figure 26 Galderma laboratories (Nestle Skin Health S.A): Segmental Revenue
Figure 27 Galderma laboratories (Nestle Skin Health S.A): Geographical Revenue
Figure 28 Obagi Cosmeceuticals LLC: Key Financials
Figure 29 Obagi Cosmeceuticals LLC: Segmental Revenue
Figure 30 Obagi Cosmeceuticals LLC: Geographical Revenue
Figure 31 Pierre Fabre: Key Financials
Figure 32 Pierre Fabre: Segmental Revenue
Figure 33 Pierre Fabre: Geographical Revenue
Figure 34 Pierre Fabre: Key Financials
Figure 35 Pierre Fabre: Segmental Revenue
Figure 36 Pierre Fabre: Geographical Revenue
Figure 37 SkinCeuticals International: Key Financials
Figure 38 SkinCeuticals International: Segmental Revenue
Figure 39 SkinCeuticals International: Geographical Revenue
Figure 40 Vivier Pharma: Key Financials
Figure 41 Vivier Pharma: Segmental Revenue
Figure 42 Vivier Pharma: Geographical Revenue
Β
Β Hyperpigmentation Disorders Treatment Market Segmentation
Hyperpigmentation Disorders Treatment Type Outlook (USD Billion, 2018-2030)
Topical Drugs
Chemical Peels
Laser Therapy
Hyperpigmentation Disorders Treatment Disease Indication Outlook (USD Billion, 2018-2030)
Melasma
Solar Lentigines
Hyperpigmentation Disorders Treatment End User Outlook (USD Billion, 2018-2030)
Hospitals
Others
Hyperpigmentation Disorders Treatment Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
North America Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
North America Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
North America Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
US Outlook (USD Billion, 2018-2030)
US Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
US Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
US Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
CANADA Outlook (USD Billion, 2018-2030)
CANADA Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
CANADA Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
CANADA Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Europe Outlook (USD Billion, 2018-2030)
Europe Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Europe Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Europe Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Germany Outlook (USD Billion, 2018-2030)
Germany Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Germany Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Germany Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
France Outlook (USD Billion, 2018-2030)
France Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
France Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
France Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
UK Outlook (USD Billion, 2018-2030)
UK Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
UK Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
UK Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
ITALY Outlook (USD Billion, 2018-2030)
ITALY Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
ITALY Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
ITALY Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Β
SPAIN Outlook (USD Billion, 2018-2030)
Spain Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Spain Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Spain Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Rest Of Europe Outlook (USD Billion, 2018-2030)
Rest Of Europe Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
REST OF EUROPE Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
REST OF EUROPE Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Asia-Pacific Outlook (USD Billion, 2018-2030)
Asia-Pacific Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Asia-Pacific Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Asia-Pacific Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
China Outlook (USD Billion, 2018-2030)
China Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
China Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
China Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Japan Outlook (USD Billion, 2018-2030)
Japan Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Japan Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Japan Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
India Outlook (USD Billion, 2018-2030)
India Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
India Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
India Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Australia Outlook (USD Billion, 2018-2030)
Australia Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Australia Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Australia Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
Rest of Asia-Pacific Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Rest of Asia-Pacific Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Rest of Asia-Pacific Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Rest of the World Outlook (USD Billion, 2018-2030)
Rest of the World Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Rest of the World Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Rest of the World Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Β
Middle East Outlook (USD Billion, 2018-2030)
Middle East Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Middle East Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Middle East Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Africa Outlook (USD Billion, 2018-2030)
Africa Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Africa Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Africa Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Latin America Outlook (USD Billion, 2018-2030)
Latin America Hyperpigmentation Disorders Treatment by Type
Topical Drugs
Chemical Peels
Laser Therapy
Latin America Hyperpigmentation Disorders Treatment by Disease Indication
Melasma
Solar Lentigines
Latin America Hyperpigmentation Disorders Treatment by End User
Hospitals
Others
Β
Β